50.62
price up icon7.70%   3.62
after-market 시간 외 거래: 51.50 0.88 +1.74%
loading
전일 마감가:
$47.00
열려 있는:
$48.12
하루 거래량:
62,144
Relative Volume:
0.53
시가총액:
$462.18M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-
EPS:
-
순현금흐름:
$-82.84M
1주 성능:
+1.85%
1개월 성능:
-33.27%
6개월 성능:
-0.35%
1년 성능:
+31.00%
1일 변동 폭
Value
$47.41
$51.50
1주일 범위
Value
$44.65
$51.50
52주 변동 폭
Value
$30.00
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
명칭
Korro Bio Inc
Name
전화
617-468-1999
Name
주소
60 FIRST STREET, CAMBRIDGE
Name
직원
101
Name
트위터
Name
다음 수익 날짜
2024-12-08
Name
최신 SEC 제출 서류
Name
KRRO's Discussions on Twitter

KRRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
KRRO 50.62 462.18M 0 -81.17M -82.84M 0.00
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-28 재확인 H.C. Wainwright Buy
2024-02-27 개시 BMO Capital Markets Outperform
2023-12-04 개시 H.C. Wainwright Buy
2023-11-29 개시 RBC Capital Mkts Outperform
2023-11-10 개시 Piper Sandler Overweight
2023-02-15 다운그레이드 Chardan Capital Markets Buy → Neutral
2023-02-13 다운그레이드 Cowen Outperform → Market Perform
2021-09-22 다운그레이드 Goldman Buy → Neutral
2021-01-27 업그레이드 JP Morgan Neutral → Overweight
2020-12-22 개시 B. Riley Securities Buy
2020-07-14 개시 Oppenheimer Outperform
2020-05-18 다운그레이드 JP Morgan Overweight → Neutral
2019-10-28 개시 Cowen Outperform
2019-10-28 개시 Goldman Buy
2019-10-28 개시 JP Morgan Overweight
모두보기

Korro Bio Inc 주식(KRRO)의 최신 뉴스

pulisher
04:24 AM

Korro to Participate in Upcoming Investor Conferences - The Manila Times

04:24 AM
pulisher
04:01 AM

Korro Bio CEO to Present at Major Healthcare Conferences in December | KRRO Stock News - StockTitan

04:01 AM
pulisher
07:48 AM

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - The Manila Times

07:48 AM
pulisher
Nov 18, 2024

Jones Trading Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - MSN

Nov 18, 2024
pulisher
Nov 18, 2024

Korro Bio FY2024 EPS Forecast Increased by HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

William Blair Has Positive View of Korro Bio FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Eventide Asset Management's Strategic Reduction in Korro Bio Inc Holdings - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP's Strategic Acquisition of Korro Bio Inc Shares - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Korro to Present at the Jefferies London Healthcare Conference - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Korro Bio to Present RNA-Editing Breakthroughs at Jefferies London Healthcare Conference | KRRO Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Korro Bio’s Progress and Financial Updates - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for growth - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

William Blair Reiterates "Outperform" Rating for Korro Bio (NASDAQ:KRRO) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Reduces Stake in Korro Bio Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Korro Bio Partners with Novo Nordisk, Reports $169M Cash Position Despite Widening Losses | KRRO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 08, 2024

4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Korro Bio (NASDAQ:KRRO) Stock Price Up 10.9%Here's What Happened - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Korro Bio files in Australia to begin first-in-human study of KRRO-110 for AATD - BioWorld Online

Nov 05, 2024
pulisher
Nov 04, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap DownHere's Why - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Bio, Inc. Announces Submission to Bellberry HREC for Phase 1/2 Clinical Study of KRRO-110 for AATD - Marketscreener.com

Nov 04, 2024
pulisher
Oct 28, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 5.1%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond James - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Raymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy Recommendation - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Korro Bio price target raised to $105 from $95 at RBC Capital - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Royal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio initiated with a Strong Buy at Raymond James - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio shares target lifted, buy rating on RNA editing potential - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 4.1%Should You Sell? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio price target raised to $115 from $100 at H.C. Wainwright - TipRanks

Oct 18, 2024
pulisher
Oct 17, 2024

BMO maintains steady target on Korro Bio shares By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 17, 2024

Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury

Oct 17, 2024
pulisher
Oct 16, 2024

500: Something went wrong - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks - Barchart

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Korro Bio shares - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

What is KRRO’s price-to-sales ratio telling us about the company’s value? - US Post News

Oct 16, 2024

Korro Bio Inc (KRRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Korro Bio Inc 주식 (KRRO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Agarwal Vineet
Chief Financial Officer
Nov 11 '24
Sale
70.00
800
56,000
0
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):